Tag Archives: US

US and Europe At Risk from Substandard Medicines

By Julian Upton | Published: February 25, 2010
Guest blog by Helen Disney, Chief Executive and Founder of the Stockholm Network, a pan-European think tank. When most of us look at taking a new medicine we tend to think it will make us better. Some of us may think about possible side effects but few of us expect the medicines we take to actually [...]
Posted in Biotech, Emerging Markets, Europe, Global, Guest Blog, Regulatory, Safety | Also tagged , , , , , , , , , , | Leave a comment

The Trouble with Transparency

By George Koroneos | Published: November 6, 2009
Guest blog by Jacky Law A couple of weeks ago I attended an industry awards dinner and had an interesting conversation with an eminent doctor who shall remain nameless. The doctor in question works in a highly specialized area and frequently talks about her research at conferences around the world. She always travels first-class and has [...]
Posted in Guest Blog, Strategy | Also tagged , , , , , , | Leave a comment

Caraco Pharma Eliminates 350 Jobs

By George Koroneos | Published: July 8, 2009
Caraco Pharmaceutical Labs announced on Monday that it will eliminate half its workforce—approximately 350 positions—but added that the number could grow as the generics firm deals with a voluntary manufacturing shutdown stemming from an FDA investigation. Last month, US marshalls seized an undisclosed amount of drug ingredients and products in a raid at the company’s Michigan [...]
Posted in Strategy | Also tagged , , , , , , , | 1 Comment